Published: Dec 23, 2025, 22:49 IST | Updated: Dec 23, 2025, 22:49 IST
The U.S. FDA approved a pill version of the weight-loss injection 'Wegovy', which is likely to be launched in January 2026. During its clinical trials, close to 1300 participants experienced an average weight loss of 16.6% after 64 weeks. Meanwhile, Orforglipron- an oral pill manufactured by U.S. drugmaker Eli Lilly is awaiting regulatory clearance.